А. С. Авдеева

450 total citations
69 papers, 274 citations indexed

About

А. С. Авдеева is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, А. С. Авдеева has authored 69 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Rheumatology, 23 papers in Immunology and 19 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in А. С. Авдеева's work include Rheumatoid Arthritis Research and Therapies (44 papers), Systemic Lupus Erythematosus Research (29 papers) and Monoclonal and Polyclonal Antibodies Research (19 papers). А. С. Авдеева is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (44 papers), Systemic Lupus Erythematosus Research (29 papers) and Monoclonal and Polyclonal Antibodies Research (19 papers). А. С. Авдеева collaborates with scholars based in Russia, Tajikistan and United Kingdom. А. С. Авдеева's co-authors include Е. Л. Насонов, Т. В. Попкова, Yury P. Rubtsov, Daniyar T. Dyikanov, Е Н Александрова, А. М. Лила, L. P. Ananyeva, А. А. Новиков, М. Е. Диатроптов and Д. Е. Каратеев and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Biochimie.

In The Last Decade

А. С. Авдеева

47 papers receiving 246 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
А. С. Авдеева Russia 9 186 70 66 61 31 69 274
Nishanthi Thalayasingam United Kingdom 7 97 0.5× 103 1.5× 98 1.5× 35 0.6× 21 0.7× 10 308
Srilakshmi M. Sharma United Kingdom 10 260 1.4× 50 0.7× 64 1.0× 41 0.7× 12 0.4× 28 490
Ulf Bergström Sweden 8 223 1.2× 61 0.9× 34 0.5× 31 0.5× 18 0.6× 14 319
Claudia Schinocca Italy 6 158 0.8× 207 3.0× 74 1.1× 67 1.1× 13 0.4× 12 391
Melinda Kedves Hungary 5 172 0.9× 85 1.2× 32 0.5× 59 1.0× 18 0.6× 6 238
Xavier M Teitsma Netherlands 7 132 0.7× 35 0.5× 36 0.5× 53 0.9× 18 0.6× 16 181
Mikhail Volkov Netherlands 7 128 0.7× 84 1.2× 50 0.8× 22 0.4× 81 2.6× 17 239
Arno W. van Kuijk Netherlands 8 238 1.3× 131 1.9× 55 0.8× 94 1.5× 49 1.6× 13 336
Marta Novella-Navarro Spain 9 172 0.9× 49 0.7× 26 0.4× 41 0.7× 25 0.8× 41 243
Jack Godsell Australia 6 92 0.5× 171 2.4× 40 0.6× 23 0.4× 18 0.6× 9 231

Countries citing papers authored by А. С. Авдеева

Since Specialization
Citations

This map shows the geographic impact of А. С. Авдеева's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by А. С. Авдеева with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites А. С. Авдеева more than expected).

Fields of papers citing papers by А. С. Авдеева

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by А. С. Авдеева. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by А. С. Авдеева. The network helps show where А. С. Авдеева may publish in the future.

Co-authorship network of co-authors of А. С. Авдеева

This figure shows the co-authorship network connecting the top 25 collaborators of А. С. Авдеева. A scholar is included among the top collaborators of А. С. Авдеева based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with А. С. Авдеева. А. С. Авдеева is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Попкова, Т. В., et al.. (2025). Effect of interleukin 6 blockers on body composition, adipocytokines and insulin-like growth factor 1 in patients with rheumatoid arthritis. Rheumatology Science and Practice. 63(3). 298–304.
2.
Авдеева, А. С., et al.. (2025). Immunophenotypes of Systemic Lupus Erythematosus—Features of Clinical and Laboratory Disorders. Doklady Biochemistry and Biophysics. 522(1). 315–322.
3.
Efremova, Irina, Roman Maslennikov, Medvedev Os, et al.. (2024). Gut Microbiota and Biomarkers of Intestinal Barrier Damage in Cirrhosis. Microorganisms. 12(3). 463–463. 24 indexed citations
4.
Роживанов, Р. В., et al.. (2024). Hypogonadism in men with inflammatory joint diseases: Frequency and clinical characteristics. Terapevticheskii arkhiv. 96(5). 486–493. 3 indexed citations
5.
Авдеева, А. С., et al.. (2024). Immunophenotypes of systemic lupus erythematosus – features of clinical and laboratory disorders. SHILAP Revista de lepidopterología. 62(4). 394–401.
6.
Авдеева, А. С., et al.. (2024). Clinical Features of ACPA-Negative and ACPA-Positive Variants of Rheumatoid Arthritis. Doklady Biochemistry and Biophysics. 517(1). 243–249.
7.
Насонов, Е. Л., et al.. (2023). Rheumatoid arthritis as a clinical and immunological syndrome: focus on the seronegative subtype of the disease. SHILAP Revista de lepidopterología. 61(3). 276–291. 5 indexed citations
9.
Авдеева, А. С., et al.. (2023). Different Clinical Relevance of Anti-Citrullinated Protein Antibodies in RA Patients. Doklady Biochemistry and Biophysics. 511(1). 187–194.
10.
Авдеева, А. С., et al.. (2023). Clinical significance of anti-DFS70 in immunoinflammatory rheumatic diseases (review). SHILAP Revista de lepidopterología. 61(1). 100–105. 1 indexed citations
11.
Насонов, Е. Л., et al.. (2023). The role of interleukin 17 in the pathogenesis of rheumatoid arthritis. Are there any prospects for the use of IL-17 inhibitors?. SHILAP Revista de lepidopterología. 61(2). 165–180. 4 indexed citations
12.
Авдеева, А. С., et al.. (2020). Regulatory T cells in patients with early untreated rheumatoid arthritis: Phenotypic changes in the course of methotrexate treatment. Biochimie. 174. 9–17. 31 indexed citations
13.
Авдеева, А. С., et al.. (2019). Evaluation of rituximab therapy in real clinical practice (according to the OREL registry of patients with rheumatoid arthritis. SHILAP Revista de lepidopterología. 57(3). 274–279. 1 indexed citations
14.
Авдеева, А. С., et al.. (2018). IMMUNOLOGICAL EFFECTS OF A RITUXIMAB BIOSIMILAR (ACELBIA, BIOCAD) IN PATIENTS WITH RHEUMATOID ARTHRITIS. SHILAP Revista de lepidopterología. 3 indexed citations
16.
Лучихина, Е. Л., Д. Е. Каратеев, G. Lukina, et al.. (2016). POSSIBILITIES FOR PRESERVING THE RESULTS OF TREATMENT IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AFTER DOSE REDUCTION AND/OR DISCONTINUATION OF BIOLOGICAL AGENTS: A REMARCA STUDY. Modern Rheumatology Journal. 10(4). 16–20. 2 indexed citations
17.
Авдеева, А. С., et al.. (2016). Relationship between matrix metalloproteinase-3 levels and articular destructive changes in early and extended rheumatoid arthritis. Terapevticheskii arkhiv. 88(5). 13–13. 1 indexed citations
18.
Авдеева, А. С., А. А. Новиков, Е Н Александрова, et al.. (2014). CHANGES OF CYTOKINE LEVELS DURING THERAPY WITH METHOTREXATE AND ADALIMUMAB IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS (REMARCA STUDY). SHILAP Revista de lepidopterología. 1 indexed citations
19.
Авдеева, А. С., et al.. (2014). AB0370 Association of Clinical Efficacy with Serum Level of Adalimumab (ADA) and Anti- Adalimumab Antibody Levels in Patients with Early Rheumatoid Arthritis (RA). Annals of the Rheumatic Diseases. 73. 927–927. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026